<DOC>
	<DOCNO>NCT02680340</DOCNO>
	<brief_summary>The primary purpose study demonstrate POLARSTEM™ Ti/HA cumulative femoral stem revision rate 10 year . The secondary purpose study provide 10 year safety effectiveness data POLARSTEM™ Ti/HA term radiographic clinical performance</brief_summary>
	<brief_title>POLARSTEM Retrospective Multicenter Study</brief_title>
	<detailed_description>This multicenter retrospective longterm clinical outcome study conduct 6 hospital France . 502 subject undergone THA POLARSTEM™ 2002 2005 enrol study clinical radiographically follow least 10 year . Subjects reach 10-year post surgery timepoint invite 10-year post-operative follow-up visit obtain clinical radiographic outcome measure .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1 . Subject require receive primary total hip arthroplasty 2002 2005 . 2 . Subject receive POLARSTEM™ Ti/HA unilateral bilateral , due severe hip joint damage result arthrosis , degenerative disease , traumatic event , inflammatory rheumatoid process . 3 . Subject receive noncemented POLARSYSTEM ( POLARSTEM™ Ti/HA combination POLARCUP™ ) . 4 . Subject age 18 75 time surgery . 5 . Signed Informed Consent ( ICF ) . 1 . Subject receive cemented POLARSTEM™ . 2 . Previously fail endoprosthesis and/or THR component relevant hip . 3 . Medical mental health condition could impair stubject 's ability willingness comply study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Total Hip Arthroplasty THA</keyword>
</DOC>